Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1999 | 12-1998 | |
| Cash Flows From Operating Activities | ||
| Net Income | -2,650 | -2,650 |
| Depreciation Amortization | 690 | 330 |
| Other Working Capital | 260 | 1,660 |
| Other Operating Activity | 0 | 30 |
| Operating Cash Flow | $-1,700 | $-630 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -5,400 | -5,340 |
| Other Investing Activity | -1,770 | -410 |
| Investing Cash Flow | $-7,170 | $-5,750 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 11,910 | 810 |
| Financing Cash Flow | $11,910 | $810 |
| Beginning Cash Position | 1,020 | 27,020 |
| End Cash Position | 4,060 | 21,440 |
| Net Cash Flow | $3,030 | $-5,570 |
| Free Cash Flow | ||
| Operating Cash Flow | -1,700 | -630 |
| Free Cash Flow | -1,700 | -630 |